Clinical trial

AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes

NCT00359112

Study summary

ClinicalTrials.gov

AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record metformin Normalized identity: metformin View linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention sulphonylurea Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Avandamet Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-02-01

PhasePHASE3

Conditions

Non-Insulin-Dependent Diabetes Mellitusunresolved

Interventions

metforminDRUG · verified · RxNorm: metformin

sulphonylureaDRUG

AvandametDRUG

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

MadridSpain4 BarcelonaSpain2 BrusselsBelgium2 ZurichSwitzerland2 DublinIreland2 VilniusLithuania2 KaunasLithuania2 EssenNorth Rhine-Westphalia, Germany2 WinterthurSwitzerland2 GlasgowLanarkshire, United Kingdom2 ParisFrance1 ValenciaSpain1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00359112 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.